ロード中...
New Protease Inhibitors for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Author Names
BACKGROUND: Chronic hepatitis C (HCV) is a difficult to treat disease affecting over 3 million Americans. Protease inhibitors increase the effectiveness of standard therapy but are costly. A genetic assay may identify patients most likely to benefit from this treatment advance. OBJECTIVE: Cost-effec...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3586733/ https://ncbi.nlm.nih.gov/pubmed/22351713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1059/0003-4819-156-4-201202210-00005 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|